Cholinesterase inhibitor blockade and its prevention by statins of sympathetic α7-nAChR-mediated cerebral nitrergic neurogenic vasodilation

Journal of Cerebral Blood Flow and Metabolism

Volumn 26, Issue 12, 2006, Pages 1562-1576

  Mozayan, Mansoor ^a   Chen, Mei Fang ^b   Si, Minliang ^a   Chen, Po Yi ^b   Premkumar, Louis S ^a   Lee, Tony J F ^a,b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Cerebral arterial dilation; Vascular dementia

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ALPHA BUNGAROTOXIN; ATROPINE; CHOLINE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; COMPACTIN; GALANTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENALINE; MEVINOLIN; NEOSTIGMINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHYSOSTIGMINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BASILAR ARTERY; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; MALE; NERVE ENDING; NERVE STIMULATION; NONHUMAN; OOCYTE; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; SUPERIOR CERVICAL GANGLION; SWINE; SYMPATHETIC NERVE; SYMPATHETIC NERVE CELL; XENOPUS;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BASILAR ARTERY; CALCIUM SIGNALING; CELLS, CULTURED; CHOLINESTERASE INHIBITORS; FEMALE; GENE EXPRESSION; MALE; MICROSCOPY, CONFOCAL; NITRERGIC NEURONS; NITRIC OXIDE; OOCYTES; ORGAN CULTURE TECHNIQUES; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTORS, NICOTINIC; SUPERIOR CERVICAL GANGLION; SWINE; VASODILATION; XENOPUS;

EID: 33751309819     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600310     Document Type: Article

References (61)

1. Aviram M, Rosenblat M, Bisgaier CL, Newton RS (1998) Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. Atherosclerosis 138:271-80
2. Bartus RT, Dean RL, III, Beer B, Lippa (1982) The cholinergic hypothesisof geriatric memory dysfunction. Science 217:408-14
3. + of the muscle-type ClC chloride channels. J Gen Physiol 118:23-32
4. Chen MF, Chen TY (2003) Side-chain charge effects and conductance determinants in the pore of ClC-0 chloride channels. J Gen Physiol 122:133-45
5. Clarke PB, Reuben M, el-Bizri H (1994) Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum. Br J Pharmacol 111:695-702
6. Colrain IM, Mangan GL, Pellett OL, Bates TC (1992) Effects of post-learning smoking on memory consolidation. Psychopharmacology (Berlin) 108:448-51
7. Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, et al, AD2000 Collaborative Group (2004) donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 363:2105-15
8. Couturier S, Bertrand D, Matter JM, Hernandez MC, Bertrand S, Millar N et al (1990) A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron 5:847-56
9. 2+ signals and neurotransmitter release. Mol Pharmacol 64:1217-26
10. Darvesh S, Martin E, Walsh R, Rockwood K (2004) Differential effects of lipid-lowering agents on human cholinesterases. Clin Biochem 37:42-9
11. Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M et al (1999) Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 281:1401-6
12. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA et al (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:8880-5
13. Fabian-Fine R, Skehel P, Errington ML, Davies HA, Sher E, Stewart MG et al (2001) Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci 21:7993-8003
14. Felix R, Levin ED (1997) Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81:1009-17
15. Fleming WW, Westfall DP, De La Lande IS, Jellett LB (1972) Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther 181:339-45
16. Grady D (April 7, 2004) Minimal benefit is seen in drugs for Alzheimer's. New York Times
17. Hillier V, Salib E (1997) A case-control study of smoking and Alzheimer's disease. Int J Geriatr Psychiatr 12:295-300
18. Holscher C, Rose SP (1992) An inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neurosci Lett 145:165-7
19. Hsu SH, Tsou TC, Chiu SJ, Chao JI. (2005) Inhibition of alpha7-nicotinic acetylcholine receptor expression by arsenite in the vascular endothelial cells. Toxicol Lett 159:47-59
20. Ibach B, Haen E (2004) Acetylcholinesterase inhibition in Alzheimer's disease. Curr Pharm Des 10:231-51
21. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ et al (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols asactive intermediates. J Pharmacol Exp Ther 218:739-49
22. Jagust WJ, Budinger TF, Reed BR (1987) The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 44:258-62
23. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA (2000) Statins and the risk of dementia. Lancet 356:1627-31
24. Jonnala RR, Buccafusco JJ (2001) Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J Neurosci Res 66:565-72
25. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H et al (1997) Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann Neurol 42:159-63
26. Kimura T, Yu JG, Edvinsson L, Lee TJ-F (1997) Cholinergic, nitric oxidergic innervation in cerebral arteries of the cat. Brain Res 773:117-24
27. Lee TJ-F (2000) Nitric oxide and the cerebral vascular function. J Biomed Sci 7:16-26
28. Lee TJ-F, Kinkead LR, Sarwinski S (1982) Norepinephrine and acetylcholine transmitter mechanisms in large cerebral arteries of the pig. J Cereb Blood Flow Metab 2:439-50
29. Lee TJ-F, Su C, Bevan JA (1976) Neurogenic sympathetic vasoconstriction of the rabbit basilar artery. Circ Res 39:120-6
30. Lee TJ-F, Zhang W, Sarwinski S (2000) Presynaptic 2-adrenoceptors mediate nicotine-induced NOergic dilation in porcine basilar arteries. Am J Physiol 279:H808-16
31. Levin ED, Bettegowda C, Blosser J, Gordon J (1999) ARR17779, and alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10:675-80
32. Lips KS, Bruggmann D, Pfeil U, Vollerthun R, Grando SA, Kummer W (2005) Nicotinic acetylcholine receptors in rat and human placenta. Placenta 26:735-46
33. Liu J, Lee TJ-F (1999) Mechanism of prejunctional muscarinic receptor-mediated inhibition of neurogenic vasodilation in cerebral arteries. Am J Physiol 276(1 Part 2):H194-204
34. 2+) channels in cultured sphenopalatine ganglion: direct evidence for acetylcholine inhibition of cerebral nitrergic neurogenic vasodilation. J Pharmacol Exp Ther 302:397-405
35. Liu J, Evans MS, Brewer GJ, Lee TJ-F (2000) N-type Ca2+ channels in cultured rat sphenopalatine ganglion neurons: an immunohistochemical and electrophysiological study. J Cereb Blood Flow Metab 20:183-91
36. Marksteiner J, Schmidt R (2004) Treatment strategies in Alzheimer's disease with a focus on early pharmacological interventions. Drugs Aging 21:415-26
37. Meyer EM, Tay ET, Papke RL, Meyers C, Huang GL, de Fiebre CM (1997) 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Res 768:49-56
38. Miao FJP, Lee TJ-F (1990) Cholinergic and VIPergic innervation in cerebral arteries: a sequential double-labelling immunohistochemical study. J Cereb Blood Flow Metab 10:32-7
39. Newhouse PA, Potter A, Corwin J, Lenox R (1994) Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology 10:93-107
40. Nilsson L, Nordberg A, Hardy J, Wester P, Winblad B (1986) Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normallevel. J Neural Transm 67:275-85
41. O'Brien JT, Eagger S, Syed GM, Sahakian BJ, Levy R (1992) A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatr 55:1182-7
42. Pahan K, Sheikh FG, Namboodiri and AM, Singh I (1997) Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 100:2671-9
43. Pautler EL (1994) The possible role and treatment of deficient microcirculation regulation in age-associated memory impairment. Med Hypotheses 42:363-6
44. Pereira EF, Alkondon M, Tano T, Castro NG, Froes-Ferrao MM, Rozental R et al (1993) A novel agonist binding site on nicotinic acetylcholine receptors. J Recept Res 13:413-36
45. Purdy RE, Smith JR, Ding Y, Oveisi F, Vaziri ND, Gonick HC (1997) Lead-induced hypertension is not associated with altered vascular reactivity in vitro. Am J Hypertens 10:997-1003
46. Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R et al (2002) Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 59:223-7
47. Rylett RJ, Ball MJ, Colhoun EH (1983) Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res 289:169-75
48. Sargent PB (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403-43
49. Schuman EM, Madison DV (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254:1503-6
50. Si ML, Lee TJ-F (2001) Presynaptic 7-nicotinic acetylcholine receptors mediate nicotine-induced nitric oxidergic neurogenic. J Pharmacol Exp Ther 298:122-8
51. Si ML, Lee TJ-F (2002) 7-Nicotinic acetylcholine receptors on cerebral perivascular sympathetic nerves mediate choline-induced nitrergic neurogenic vasodilation. Circ Res 91:62-9
52. Si ML, Lee TJ-F (2003) Pb2+ inhibition of sympathetic alpha 7-nicotinic acetylcholine receptor-mediated nitrergic neurogenic dilation in porcine basilar arteries. J Pharmacol Exp Ther 305:1124-31
53. Toda N, Okamura T (1998) Cerebral vasodilators. Jpn J Pharmacol 76:349-67
54. Tohgi H, Abe T, Kimura M, Saheki M, Takahashi S (1996) Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types ascompared with Alzheimer-type dementia. J Neural Transm 103:1211-20
55. van Duijn CM, Hofman A (1991) Relation between nicotine intake and Alzheimer's disease. BMJ 302:1491-4
56. Wei CY, Huang KC, Chou YH, Hsieh PF, Lin KH, Lin WW (2005) The role of Rho-associated kinase in differential regulat. Mol Pharmacol 2005, Nov 29; [E-pub ahead of print]
57. Whiteaker P, Davies AR, Marks MJ, Blagbrough IS, Potter BV, Wolstenholme AJ et al (1999) An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur J Neurosci 11:2689-96
58. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E et al (1995) Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-14
59. Yu JG, Kimura T, Chang XF, Lee TJ-F (1998) Segregation of VIPergic-nitric oxidergic and cholinergic-nitric oxidergic innervation in porcine middle cerebral arteries. Brain Res 801:78-87
60. Zdrenghea D, Bodizs G, Predescu D, Oprea M, Zdrenghea M (2002) The effect of Simvastatin upon serum pseudocholinesterase and plasmatic factor VII. Rom J Intern Med 40:3-9
61. Zhang W, Edvinsson L, Lee TJ-F (1998) Mechanism of nicotine-induced neurogenic vasodilation in the porcine basilar artery. J Pharmacol Exp Ther 284:790-7